[FREE Report] 5 Growth Stocks Under $49
Stay focused on the long-term with these 5 growth stock picks.
Learn More.

IMC Insider Trading (Immuron)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$0.00

Immuron Insider Trading History Chart

This chart shows the insider buying and selling history at Immuron by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Immuron Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for IMC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
3 Cryptos to Buy for 2022
Is your crypto portfolio ready for 2022?

With Bitcoin hitting all-time highs, now is the time to reorient your crypto plays for the coming year.

That's why Luke Lango, InvestorPlace's resident crypto expert is releasing his latest calls… completely free.

You can get them in his latest report, "3 Cryptos to Beat Bitcoin."
Just click here to claim your copy today.

Immuron Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/9/2021Ravi SavarirayanInsiderExercise900,000A$0.23A$207,000.00
6/23/2020Roger AstonInsiderBuy56,760A$0.30A$17,028.00
6/17/2020Peter AnastasiouInsiderSell4,184,808A$0.31A$1,305,660.10
6/11/2020Daniel PollockInsiderSell100,000A$0.41A$40,500.00
7/19/2019Gary JacobInsiderBuy260,000A$0.08A$21,060.00
6/19/2019Daniel PollockInsiderBuy75,000A$0.11A$7,875.00
6/3/2019Daniel PollockInsiderBuy70,000A$0.14A$9,520.00
5/28/2019Peter AnastasiouInsiderBuy500,000A$0.16A$77,500.00
See Full Table
Insider Buying at Immuron?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Immuron and related companies.

SEC Filings (Institutional Ownership Changes) for Immuron (ASX:IMC)

Immuron Limited, a biopharmaceutical company, researches and develops oral immunotherapy polyclonal antibodies for the treatment and prevention of infectious and immune modulated diseases in Australia, the United States, and internationally. The company operates through two segments, Research and Development, and Hyperimmune Products. The company markets Travelan and Protectyn for the prevention of travellers' diarrhea. Its lead product candidates include IMM-124E that is in Phase II clinical trials for non-alcoholic steatohepatitis, severe alcoholic hepatitis, and non-alcoholic fatty liver disease, as well as used in antiviral activity against the COVID-19 virus in laboratory studies; and IMM-529, a clinical stage product for clostridium difficile infections. Immuron Limited was founded in 1994 and is based in Carlton, Australia.
Read More on Immuron

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

175,856 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Immuron?

Immuron's top insider investors include:
  1. Daniel Pollock (Insider)
  2. Peter Anastasiou (Insider)
  3. Ravi Savarirayan (Insider)
  4. Roger Aston (Insider)
iPHONE WARNING: Obsolete? 
Why is Jeff Brown throwing away a perfectly good $1,000 iPhone?

According to him, Apple is about to make a critical announcement that will send shockwaves through Wall Street.

If you own a smartphone, click here now… Because this is guaranteed to affect you.

HINT: The iPhone days are coming to an end.
Click here now.